Capital, a next-generation life sciences venture capital firm co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, today announced the launch of its newest platform.

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses ... 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today ...

A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...

Surgeons at NYU Langone Health in New York City had to remove a genetically modified pig kidney from Towana Looney, 53, of ...

Grown Alchemist, the beauty brand that engineers plant-powered solutions using cutting edge biotechnology to achieve total skin health, has expanded its footprint in the US, launching with luxury ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 5.89%, which has investors questioning if this is right time to ...

Amarin Corporation plc’s AMRN share price has dipped by 6.98%, which has investors questioning if this is right time to buy.

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (UTHR) announced today that it will report its first quarter 2025 financial results before the ...

Ligand Pharmaceuticals Incorporated (“Ligand”) (Nasdaq: LGND) and Channel Therapeutics Corporation (“Channel”) (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment ...

The 340B program requires drugmakers who want to participate in Medicaid and Medicare to discount their prices for hospitals, ...